• Guideline Summary
  • NGC:010592
  • 1994 Jun (revised 2014 Nov 4)

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

  • Guideline Summary
  • NGC:009913
  • 2013 Apr

Early detection of prostate cancer: AUA guideline.

  • Guideline Summary
  • NGC:009101
  • 1996 (revised 2012 Jul 17)

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:009863
  • 2012 May 17

Risk reduction of prostate cancer with drugs or nutritional supplements.

  • Guideline Summary
  • NGC:009352
  • 2004 May (revised 2012 Oct)

Cancer screening.

  • Guideline Summary
  • NGC:009907
  • 2013 Apr

Adjuvant and salvage radiotherapy after prostatectomy: ASTRO/AUA guideline.

  • Guideline Summary
  • NGC:009848
  • 1996 (revised 2012)

Urinary incontinence in the long term care setting.

  • Guideline Summary
  • NGC:010205
  • 2008 Feb (revised 2014 Jan)

Prostate cancer: diagnosis and treatment.

  • Guideline Summary
  • NGC:010731
  • 2010 May (revised 2015 Jun)

Lower urinary tract symptoms in men: assessment and management.

  • Guideline Summary
  • NGC:010182
  • 2013

ACR Appropriateness Criteria® high-dose-rate brachytherapy for prostate cancer.

  • Guideline Summary
  • NGC:009671
  • 2005 (revised 2012)

ACR Appropriateness Criteria® prostate cancer—pretreatment detection, staging and surveillance. [Update Pending]

  • Guideline Summary
  • NGC:010181
  • 1996 (revised 2013)

ACR Appropriateness Criteria® definitive external-beam irradiation in stage T1 and T2 prostate cancer.

  • Guideline Summary
  • NGC:010470
  • 1996 (revised 2014)

ACR Appropriateness Criteria® postradical prostatectomy irradiation in prostate cancer.

  • Guideline Summary
  • NGC:011080
  • 2016

ACR Appropriateness Criteria® hematospermia.

  • Guideline Summary
  • NGC:010742
  • 2005 Jun (revised 2015 Jun 23)

Suspected cancer: recognition and referral.

  • Guideline Summary
  • NGC:010223
  • 2012 Oct 31

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer.

  • Guideline Summary
  • NGC:010722
  • 2015 Jun 2

Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index.

  • Expert Commentary

Reflections from the 2014 Guidelines International Network Conference

  • Guideline Summary
  • NGC:009235
  • 1995 (revised 2012)

ACR Appropriateness Criteria® metastatic bone disease.